Related Experiment Video
Updated: Jun 19, 2026
10:49
Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
Advances in stem cell research for Amyotrophic Lateral Sclerosis
Sophia T Papadeas1, Nicholas J Maragakis
1Johns Hopkins University, 600 N. Wolfe St., Meyer 6-119, Baltimore, MD 21287, USA.
Current Opinion in Biotechnology
|October 13, 2009
Summary
Amyotrophic Lateral Sclerosis (ALS) involves motor neuron loss, but other cells like astrocytes and microglia also contribute. Induced pluripotent stem cells (iPSCs) offer new avenues for ALS research and potential treatments.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Genetics
Background:
- Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease primarily affecting motor neurons.
- Recent research indicates that non-neuronal cells, such as astrocytes and microglia, play a significant role in ALS pathogenesis.
- This highlights the complexity of ALS beyond primary motor neuron degeneration.
Purpose of the Study:
- To explore the potential of stem cell-based strategies for neuroprotection in ALS.
- To leverage induced pluripotent stem cell (iPSC) technology for ALS research.
- To investigate the utility of patient-derived iPSCs for autologous transplantation, drug discovery, and understanding disease mechanisms.
Main Methods:
- Utilizing induced pluripotent stem cell (iPSC) technology to generate motor neuron cell lines from ALS patients.
- Developing stem-cell-replacement strategies targeting implicated non-neuronal cell types.
- Establishing patient-specific cell models for disease investigation.
Main Results:
- iPSC technology enables the creation of patient-specific motor neuron cell lines.
- Stem-cell-replacement strategies show potential for neuroprotection in ALS models.
- These cell lines provide a platform for studying ALS pathobiology.
Conclusions:
- Induced pluripotent stem cells (iPSCs) derived from ALS patients are a valuable tool for research.
- iPSC technology facilitates the development of personalized medicine approaches, including autologous cell transplantation.
- Further research using iPSC-derived cells can enhance understanding of ALS and accelerate drug discovery.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...